(Q80665192)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18261784%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

title

Improved tolerance of primary chemotherapy with reduced-dose carboplatin and paclitaxel in elderly ovarian cancer patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18261784%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

1 reference

1 reference

Amanda Nickles Fader

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18261784%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Vivian von Gruenigen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18261784%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Heidi Gibbons

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18261784%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Fadi Abushahin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18261784%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

David Starks

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18261784%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Maurie Markman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18261784%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Jerome Belinson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18261784%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Peter Rose

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18261784%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

publication date

7 February 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18261784%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18261784%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

109

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18261784%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18261784%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

33-38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18261784%20AND%20SRC:MED&resulttype=core&format=json

Ovarian cancer in the elderly: an analysis of Surveillance, Epidemiology, and End Results Program data

2 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.001

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.001

Ovarian cancer. Survival and treatment differences by age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.001

Treatment patterns by decade of life in elderly women (> or =70 years of age) with ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.001

Management of ovarian cancer in patients older than 80 years of Age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.001

Altered clearance of unbound paclitaxel in elderly patients with metastatic breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.001

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.001

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.001

Comorbidity and functional status are independent in older cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.001

Can older cancer patients tolerate chemotherapy? A prospective pilot study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.001

The application of the principles of geriatrics to the management of the older person with cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.001

Age as a prognostic factor in ovarian carcinoma. The Gynecologic Oncology Group experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.001

Dose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.001

Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.001

10.1016/J.YGYNO.2008.01.001

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18261784%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference